Loading...

PODCAST

Pharmaceutical Executive

Pharmaceutical Executive Podcast

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.

science life sciences

All Episodes

3:07

Pharmaceutical Executive Daily: Lilly and NVIDIA...

Pharmaceutical Executive ·

2025/10/29

In today’s Pharmaceutical Executive Daily, we cover Eli Lilly’s partnership with NVIDIA to develop an AI supercomputer for drug discovery, a surge in biotech funding rounds and public offerings, and the FDA approval of Merck’s Winrevair for pulmonary arterial hypertension.

en-us

3:03

Pharmaceutical Executive Daily: Organon CEO Kevin Ali...

Pharmaceutical Executive ·

2025/10/28

In today’s Pharmaceutical Executive Daily, we cover the resignation of Organon CEO Kevin Ali following an internal investigation tied to Nexplanon sales, GSK’s $357 million agreement with Syndivia to expand its antibody-drug conjugate portfolio, and new guidance from the American College of Surgeons classifying obesity as a treatable condition.

en-us

3:06

Pharmaceutical Executive Daily: New Research Suggests...

Pharmaceutical Executive ·

2025/10/27

In today’s Pharmaceutical Executive Daily, we cover the FDA approval of Bayer’s Lynkuet for menopausal hot flashes, new research suggesting Ozempic may reduce biological age, and Novartis’ $12 billion merger agreement to acquire Avidity Biosciences.

en-us

3:00

Pharmaceutical Executive Daily: TrumpRx's Implication...

Pharmaceutical Executive ·

2025/10/24

In today’s Pharmaceutical Executive Daily, we cover the emergence of TrumpRx and its implications for direct-to-consumer drug commercialization, new funding momentum across rare disease R&D, and Eli Lilly’s definitive agreement to acquire Aderum Biotechnologies.

en-us

3:02

Pharmaceutical Executive Daily: Novo Nordisk's Shares...

Pharmaceutical Executive ·

2025/10/23

In today’s Pharmaceutical Executive Daily, we cover market reaction to Novo Nordisk’s recent board shake-up, MJH Life Sciences’ acquisition of BPD Healthcare to strengthen its health system reach, and why clinical trial site satisfaction is becoming a key competitive differentiator for sponsors and CROs.

en-us

2:56

Pharmaceutical Executive Daily: Novo Nordisk's Board...

Pharmaceutical Executive ·

2025/10/22

In today’s Pharmaceutical Executive Daily, we cover major leadership changes at Novo Nordisk, Kenvue’s request for the FDA to reject a petition calling for Tylenol label changes, and industry insights from Bob Mauch on building a stronger, more resilient pharmaceutical supply chain.

en-us

2:58

Pharmaceutical Executive Daily: Merck's $70 Billion...

Pharmaceutical Executive ·

2025/10/21

In today’s Pharmaceutical Executive Daily, we cover Merck’s $70 billion expansion of U.S. operations, the FDA’s latest approvals for Novo Nordisk’s Rybelsus and Roche’s Gazyva, and a new digital health partnership between Amazon and WeightWatchers bringing prescription weight-loss drugs directly to consumers.

en-us

2:49

Pharmaceutical Executive Daily: FDA's National...

Pharmaceutical Executive ·

2025/10/20

In today’s Pharmaceutical Executive Daily, we cover the FDA’s creation of a new National Priority Voucher Program, the market reaction to President Trump’s remarks on GLP-1 drug prices, and how autonomous AI is transforming omnichannel marketing in pharma.

en-us

14:33

Shifting Focus in Autoimmune Diseases

Pharmaceutical Executive ·

2025/10/20

Artax Biopharma’s CEO Rob Armstrong explains recent shifts in autoimmune R&D before discussing his leadership style.

en-us

3:01

Pharmaceutical Executive Daily: EMD Serono’s...

Pharmaceutical Executive ·

2025/10/17

In today’s Pharmaceutical Executive Daily, we explore how antibody-drug conjugate collaborations are moving beyond oncology into autoimmune diseases, EMD Serono’s agreement with the Trump administration to expand access to in vitro fertilization therapies, and how the obesity treatment market is evolving after GLP-1 dominance.

en-us

2:59

Pharmaceutical Executive Daily: Rethinking Workforce...

Pharmaceutical Executive ·

2025/10/16

In today’s Pharmaceutical Executive Daily, we explore how pharma leaders are rethinking workforce development at the executive level, the industry’s growing investment in rare disease therapies, and emerging opportunities and challenges in psychiatric drug development.

en-us

2:47

Pharmaceutical Executive Daily: Johnson & Johnson...

Pharmaceutical Executive ·

2025/10/15

In today’s Pharmaceutical Executive Daily, we explore Johnson & Johnson’s plan to separate its orthopaedics division into a standalone company, the global implications of the Most Favored Nation drug pricing proposal, and strategies helping small biotechs reach market faster.

en-us

3:06

Pharmaceutical Executive Daily: Direct-To-Consumer...

Pharmaceutical Executive ·

2025/10/14

In today’s Pharmaceutical Executive Daily, we cover Takeda’s new multi-year research collaboration with Nabla Bio, how tariff and pricing pressures are driving pharma toward direct-to-consumer strategies, and reports of AstraZeneca reaching an agreement with the Trump administration.

en-us

10:49

Advancing Neuroscience and Rare Disease Innovation

Pharmaceutical Executive ·

2025/10/14

Acadia Pharmaceuticals’ CEO Catherine Owen Adams discusses the current climate in R&D and details her leadership style.

en-us

2:53

Pharmaceutical Executive Daily: Policy Whiplash

Pharmaceutical Executive ·

2025/10/13

In today’s Pharmaceutical Executive Daily, we cover Ypsomed’s new North Carolina manufacturing site, how pharma leaders are maintaining strategic clarity amid policy whiplash, and Excellergy’s $70 million Series A launch to advance its trifunctional immunotherapy platform.

en-us

2:51

Pharmaceutical Executive Daily: Most Favored Nation...

Pharmaceutical Executive ·

2025/10/10

In today’s Pharmaceutical Executive Daily, we cover Bristol Myers Squibb’s $1.5 billion acquisition of Orbital Therapeutics, ongoing legal and market implications of the Most Favored Nation drug pricing proposal, and the FDA’s approval of Libtayo as an adjuvant therapy for cutaneous squamous cell carcinoma.

en-us

2:37

Pharmaceutical Executive Daily: Why DSCSA Compliance...

Pharmaceutical Executive ·

2025/10/09

In today’s Pharmaceutical Executive Daily, we cover the FDA’s approval of Johnson & Johnson’s Simponi for pediatric ulcerative colitis, why DSCSA compliance is only the beginning of pharma supply chain modernization, and the agency’s approval of Jascayd for idiopathic pulmonary fibrosis.

en-us

3:00

Pharmaceutical Executive Daily: Amgen Launches New...

Pharmaceutical Executive ·

2025/10/08

In today’s Pharmaceutical Executive Daily, we explore why medical AI success depends on more than algorithms, Amgen’s launch of its new direct-to-consumer platform AmgenNow, and AstraZeneca’s multi-target research partnership with Algen.

en-us

2:56

Pharmaceutical Executive Daily: FDA Lifts Clinical...

Pharmaceutical Executive ·

2025/10/07

In today’s Pharmaceutical Executive Daily, we cover the FDA lifting its clinical hold on Neurizon Therapeutics’ lead program Nuz-001, the agency’s export ban on Sun Pharma’s Halol facility, and new insights on how small biotechs can better navigate regulatory and market complexities.

en-us

2:40

Pharmaceutical Executive Daily: Updated Vaccine...

Pharmaceutical Executive ·

2025/10/06

Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry.In today’s Pharmaceutical Executive Daily, we cover lessons from FDA complete response letters shaping CMC strategy in cell and gene therapy, Takeda’s decision to discontinue its cell therapy research programs, and the CDC’s latest update to COVID-19 vaccination recommendations.

en-us

463 results

Similar Podcasts

Rabbit Hole of Research

Jotham Austin, II PhD, Nick Elizalde,...

Short Science Fiction Collection

Vaqrious

Planetterrian Daily

Patrick · Nerra Network

Short Wave

NPR

La Science CQFD

France Culture